Lifecome Biochemistry Co.,Ltd. (002868.SZ)
CNY 15.88
(-2.87%)
CNY 15.88
(-2.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 507 Million | 329.85 Million | 363.38 Million | 308.14 Million | 303.75 Million | 344.29 Million |
| Cost of Revenue | 611.74 Million | 339.1 Million | 303.79 Million | 214.61 Million | 202.73 Million | 225.38 Million |
| Gross Profit | -104.74 Million | -9.25 Million | 59.58 Million | 93.52 Million | 101.02 Million | 118.91 Million |
| Operating Expenses | 190.7 Million | 50.69 Million | 60.3 Million | 49.75 Million | 51.39 Million | 47.03 Million |
| Selling, General and Administrative Expenses | 27.17 Million | 16.76 Million | 19.95 Million | 17.21 Million | 24.18 Million | 23.89 Million |
| Research and Development Expenses | 31.95 Million | 21.82 Million | 24.82 Million | 19.91 Million | 18.54 Million | 14.56 Million |
| Other Expenses | 72.25 Million | 12.1 Million | 15.52 Million | 12.62 Million | 8.65 Million | -73.95 Thousand |
| Cost and Expenses | 743.13 Million | 389.79 Million | 364.1 Million | 264.37 Million | 254.12 Million | 272.41 Million |
| Operating Income | -236.13 Million | -133.75 Million | -21.29 Million | 48.02 Million | 66.98 Million | 87.19 Million |
| Interest Expense | 38.01 Million | 16.22 Million | 2.81 Million | 980.56 Thousand | 1.12 Million | 22.2 Thousand |
| Income Tax Expense | -18.27 Million | -11.38 Million | -5.9 Million | 5.5 Million | 9.17 Million | 12.43 Million |
| Earnings before Tax | -240.89 Million | -134.11 Million | -32.35 Million | 48.44 Million | 66 Million | 87.12 Million |
| Net Income | -221.81 Million | -122.72 Million | -26.44 Million | 43.2 Million | 56.96 Million | 74.68 Million |
| Earnings Per Share Basic | -1.44 | -0.80 | -0.17 | 0.28 | 0.37 | 0.48 |
| Earnings Per Share Diluted | -1.44 | -0.80 | -0.17 | 0.28 | 0.37 | 0.48 |
| Weighted Average Shares Outstanding | 154.04 Million | 153.4 Million | 153.4 Million | 153.4 Million | 156 Million | 156 Million |
| Weighted Average Shares Outstanding (Diluted) | 154.04 Million | 153.4 Million | 153.4 Million | 153.4 Million | 156 Million | 156.6 Million |
| Gross Margin | -0.21 | -0.03 | 0.16 | 0.30 | 0.33 | 0.35 |
| EBIT Margin | -0.25 | -0.01 | 0.03 | 0.27 | 0.32 | 0.35 |
| Profit Margin | -0.44 | -0.37 | -0.07 | 0.14 | 0.19 | 0.22 |
| EBITDA | -127.92 Million | -53.71 Million | 12.65 Million | 79.87 Million | 95.75 Million | 91.74 Million |
| Earnings Before Tax Margin | -0.47 | -0.41 | -0.06 | 0.16 | 0.22 | 0.25 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 143.7 Million | 166.03 Million | 159.23 Million | 109.33 Million | 507 Million | 167.63 Million |
| Cost of Revenue | 156.1 Million | 179.35 Million | 147.3 Million | 153.34 Million | 552.43 Million | 192.28 Million |
| Gross Profit | -12.4 Million | -13.31 Million | 11.93 Million | -44.01 Million | -45.42 Million | -24.65 Million |
| Operating Expenses | 40.01 Million | 30.11 Million | 36.04 Million | 32.56 Million | 82.73 Million | 17.62 Million |
| Selling, General and Administrative Expenses | 10.41 Million | -2.27 Million | 18.35 Million | -2.53 Million | - | 18.56 Million |
| Research and Development Expenses | 10.86 Million | 11.31 Million | 7.83 Million | 7.91 Million | - | 6.49 Million |
| Other Expenses | -18.72 Million | 138.68 Thousand | -9.85 Million | -591.27 Thousand | -4.76 Million | -55.72 Thousand |
| Cost and Expenses | 196.11 Million | 209.46 Million | 183.35 Million | 185.9 Million | 635.17 Million | 209.91 Million |
| Operating Income | -52.41 Million | -77.37 Million | -24.11 Million | -152.25 Million | -236.13 Million | -39.1 Million |
| Interest Expense | 10.64 Million | 15.53 Million | 15.54 Million | 22.7 Million | 37.1 Million | 2.84 Million |
| Income Tax Expense | -639.69 Thousand | -21.09 Million | -8.04 Million | -16.85 Million | -18.27 Million | 591.78 Thousand |
| Earnings before Tax | -71.64 Million | -77.23 Million | -39.55 Million | -152.85 Million | -240.89 Million | -39.16 Million |
| Net Income | -69.9 Million | -55.73 Million | -31.34 Million | -135.73 Million | -221.81 Million | -39.41 Million |
| Earnings Per Share Basic | -0.45 | -0.36 | -0.20 | -0.88 | - | -0.26 |
| Earnings Per Share Diluted | -0.45 | -0.36 | -0.20 | -0.88 | - | -0.26 |
| Weighted Average Shares Outstanding | 155.41 Million | 155.41 Million | 155.41 Million | 155.01 Million | 154.04 Million | 153.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 155.41 Million | 155.41 Million | 155.41 Million | 155.01 Million | 154.04 Million | 153.4 Million |
| Gross Margin | -0.09 | -0.08 | 0.07 | -0.40 | -0.09 | -0.15 |
| EBIT Margin | -0.42 | -0.18 | -0.07 | -0.76 | - | -0.29 |
| Profit Margin | -0.49 | -0.34 | -0.20 | -1.24 | -0.44 | -0.24 |
| EBITDA | -61 Million | -30.36 Million | -11.75 Million | -82.87 Million | - | -49.42 Million |
| Earnings Before Tax Margin | -0.36 | -0.47 | -0.15 | -1.39 | -0.47 | -0.23 |
000531
000631
301150
002845
300853
002623